BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 12632996)

  • 1. [Cholestasis. Recent diagnostic and therapeutic acquisitions].
    Marucci L; Macarri G; Benedetti A
    Recenti Prog Med; 2003 Jan; 94(1):19-24. PubMed ID: 12632996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver transplantation for primary biliary cirrhosis and primary sclerosing cholangitis: does medical treatment alter timing and selection?
    Hay JE
    Liver Transpl Surg; 1998 Sep; 4(5 Suppl 1):S9-17. PubMed ID: 9742489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of cholestatic liver diseases].
    Karvonen AL
    Duodecim; 2003; 119(6):533-9. PubMed ID: 12708340
    [No Abstract]   [Full Text] [Related]  

  • 4. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
    Stiefelhagen P
    MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
    [No Abstract]   [Full Text] [Related]  

  • 5. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [State of the art in therapeutic biliary endoscopy].
    Costamagna G; Familiari P; Iacopini F; Shah S; Marchese M
    Rev Gastroenterol Mex; 2005 Jul; 70 Suppl 1():63-82. PubMed ID: 17469411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Primary sclerosing cholangitis and primary biliary liver cirrhosis as the causes of intrahepatic cholestasis].
    Mandera M; Nowakowska-Duława E; Hartleb M
    Wiad Lek; 1992 May; 45(9-10):366-70. PubMed ID: 1441546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of autoimmune hepatic diseases].
    Bueverov AO
    Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid for the treatment of cholestatic diseases.
    Poupon RE; Poupon R
    Prog Liver Dis; 1992; 10():219-38. PubMed ID: 1296231
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endoscopic management of biliary complications after liver transplantation].
    Carlson CJ; Kowdley KV
    Rev Gastroenterol Mex; 2005 Jul; 70 Suppl 1():107-20. PubMed ID: 17469414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ursodeoxycholic acid: an alternative in the treatment of chronic cholestasis].
    Parés A; Rodés J
    Gastroenterol Hepatol; 1996 Feb; 19(2):58-67. PubMed ID: 8616682
    [No Abstract]   [Full Text] [Related]  

  • 12. The current status of ursodeoxycholate in the treatment of chronic cholestatic liver disease.
    Luketic VA; Sanyal AJ
    Gastroenterologist; 1994 Mar; 2(1):74-9. PubMed ID: 8055235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug therapy of cholestatic hepatopathies].
    Leuschner U
    Schweiz Rundsch Med Prax; 1992 Aug; 81(34):983-4. PubMed ID: 1529191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of intrahepatic cholestasis syndrome].
    Kraus MR; Scheurlen M
    MMW Fortschr Med; 2004 Jun; 146(23):34-7. PubMed ID: 15373130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholestasis and cholestatic syndromes.
    O'Leary JG; Pratt DS
    Curr Opin Gastroenterol; 2007 May; 23(3):232-6. PubMed ID: 17414837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cholestatic syndromes].
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():45-51. PubMed ID: 17471858
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term response of primary biliary cirrhosis (stage I) to therapy with ursodeoxycholic acid.
    Tromm A; May B; Klein CG; Klein R; Fisseler-Eckhoff A; Griga T
    Hepatogastroenterology; 2005; 52(63):753-6. PubMed ID: 15966198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of autoimmune and cholestatic liver disorders.
    Krok KL; Munoz SJ
    Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy with ursodeoxycholic acid in cholestatic liver disease.
    Van de Meeberg PC; van Erpecum KJ; van Berge-Henegouwen GP
    Scand J Gastroenterol Suppl; 1993; 200():15-20. PubMed ID: 8016564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance cholangiopancreatography in cholestatic diseases.
    Bolukbas C; Bolukbas FF; Horoz M; Baba ZF; Eser M; Uzunkoy A; Ucar E; Kaya Z; Guran S
    Hepatogastroenterology; 2005; 52(63):705-8. PubMed ID: 15966187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.